CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 180 enrolled
Drug / intervention
I-gel +1 moredevice
Likely dose
Not stated in record
Key inclusion· 4
  • Age ≥18 years
  • Elective surgical procedure
  • Supraglottic airway can be used and left in place throughout surgery
  • Tracheal intubation required
Key exclusion· 7
  • Class II obesity (BMI >40)
  • Age <18 years
  • ASA class 3, 4, or 5
  • Mouth opening <3 cm

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03118596
NCT03118596N/ACompleted

Fibre-optic Guided Tracheal Intubation Through Supraglottic Airway Devices - a Randomised Comparison Between I-gel and the LMA ProtectorTM

University Hospitals Coventry and Warwickshire NHS Trust·interventional·Posted Apr 18, 2017·Updated Apr 9, 2020

In Brief

A clinical study evaluating I-gel and LMA Protector for Intubation; Difficult or Failed and 2 related conditions. Completed, enrolled 180 participants across 2 sites.

Detailed Summary

The study aims to establish which of the two second generation Supraglottic Airway Devices, the I-gel or the the laryngeal ask airway (LMA) Protector, is best suited to be used as a conduit to fibreoptic bronchoscope assisted tracheal intubation. The primary outcome of this will be the time to complete the tracheal intubation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 18, 2017
Enrollment StartMay 24, 2017
Primary CompletionMar 26, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.2 years ago

Interventions

I-geldevice

Fibreoptic guided tracheal intubation is going to be performed through the I-gel supraglottic airway.

LMA Protectordevice

Fibreoptic guided tracheal intubation is going to be performed through the LMA Protector supraglottic airway.